A detailed history of Israel Englander (Millennium Management LLC) transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,193,755 shares of PSTX stock, worth $20.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,193,755
Previous 642,970 241.19%
Holding current value
$20.7 Million
Previous $1.88 Million 234.26%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.7 - $4.04 $4.19 Million - $6.27 Million
1,550,785 Added 241.19%
2,193,755 $6.27 Million
Q2 2024

Aug 14, 2024

SELL
$2.0 - $3.46 $20,886 - $36,132
-10,443 Reduced 1.6%
642,970 $1.88 Million
Q1 2024

May 15, 2024

BUY
$2.76 - $4.13 $167,904 - $251,248
60,835 Added 10.27%
653,413 $2.08 Million
Q4 2023

Feb 14, 2024

SELL
$1.83 - $3.51 $1.01 Million - $1.94 Million
-551,773 Reduced 48.22%
592,578 $1.99 Million
Q2 2023

Aug 14, 2023

BUY
$1.66 - $3.4 $280,106 - $573,712
168,739 Added 17.3%
1,144,351 $2.01 Million
Q1 2023

May 15, 2023

SELL
$3.08 - $8.73 $2.07 Million - $5.86 Million
-671,285 Reduced 40.76%
975,612 $3.01 Million
Q4 2022

Feb 14, 2023

BUY
$3.33 - $6.38 $4.98 Million - $9.54 Million
1,495,099 Added 984.93%
1,646,897 $8.73 Million
Q3 2022

Nov 14, 2022

SELL
$2.43 - $4.51 $2.09 Million - $3.88 Million
-860,717 Reduced 85.01%
151,798 $536,000
Q2 2022

Aug 15, 2022

BUY
$1.87 - $5.0 $332,727 - $889,645
177,929 Added 21.32%
1,012,515 $2.61 Million
Q1 2022

May 16, 2022

SELL
$3.22 - $7.04 $199,408 - $435,973
-61,928 Reduced 6.91%
834,586 $3.74 Million
Q4 2021

Feb 14, 2022

SELL
$6.23 - $7.6 $83,120 - $101,399
-13,342 Reduced 1.47%
896,514 $6.11 Million
Q3 2021

Nov 15, 2021

SELL
$7.09 - $10.71 $966,133 - $1.46 Million
-136,267 Reduced 13.03%
909,856 $6.63 Million
Q2 2021

Aug 16, 2021

SELL
$7.96 - $10.07 $5.72 Million - $7.23 Million
-718,382 Reduced 40.71%
1,046,123 $10.5 Million
Q1 2021

May 17, 2021

BUY
$8.51 - $11.91 $2.47 Million - $3.45 Million
289,976 Added 19.67%
1,764,505 $16.9 Million
Q4 2020

Feb 16, 2021

BUY
$8.29 - $11.7 $8.36 Million - $11.8 Million
1,008,070 Added 216.11%
1,474,529 $16.2 Million
Q3 2020

Nov 16, 2020

BUY
$8.09 - $16.25 $3.77 Million - $7.58 Million
466,459 New
466,459 $4.14 Million

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $811M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.